Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias.

Kohgo, Yutaka; Urabe, Akio; Kilinç, Yurdanur; Agaoglu, Leyla; Warzocha, Krzysztof; Miyamura, Koichi; Lim, Lay Cheng; Glaser, Sabine; Wang, Candace; Wiktor-Jedrzejczak, Wieslaw

Kohgo, Yutaka; Urabe, Akio; Kilinç, Yurdanur; Agaoglu, Leyla; Warzocha, Krzysztof; Miyamura, Koichi; Lim, Lay Cheng; Glaser, Sabine; Wang, Candace; Wiktor-Jedrzejczak, Wieslaw.

Acta Haematol ; 134(4): 233-42, 2015.

Article in En | MEDLINE | ID: mdl-26138856

Subject(s)

Anemia, Aplastic/drug therapy; Benzoates/administration & dosage; Iron Overload/drug therapy; Liver/metabolism; Myelodysplastic Syndromes/drug therapy; Triazoles/administration & dosage; Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic/metabolism; Anemia, Aplastic/pathology; Benzoates/adverse effects; Child; Child, Preschool; Deferasirox; Humans; Iron Overload/metabolism; Iron Overload/pathology; Liver/pathology; Middle Aged; Myelodysplastic Syndromes/metabolism; Myelodysplastic Syndromes/pathology; Triazoles/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Triazoles / Benzoates / Myelodysplastic Syndromes / Iron Overload / Anemia, Aplastic / Liver Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Humans / Middle aged Language: En Journal: Acta Haematol Year: 2015 Document type: Article Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links